Chief Scientific Officer
Ian Anderson has over 30 years of experience in the pharmaceutical and biotechnology industry, and most recently held the position of SVP Immunology Discovery and Scientific Innovation for Janssen Pharmaceuticals. Prior to this, Dr. Anderson was VP Immunology Scientific Innovation located at the JnJ Innovation Center in London. Before moving to JnJ, he led Respiratory and Inflammation and Autoimmune Discovery at MedImmune, and preceding this he was VP Research at Cambridge Antibody Technology. He started his career at Glaxo Group Research.
Dr. Anderson received his B.Sc. from Manchester University and Ph.D. from University College London.